Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The MHC class II antigen presentation pathway is a central process in the adaptive immune response, in which specialized antigen-presenting cells such as dendritic cells, macrophages, and B cells internalize exogenous antigens (from pathogens or the environment), process these proteins into peptides, and load the resulting fragments onto MHC class II molecules. These peptide-MHC class II complexes are then displayed on the cell surface, where they are recognized by CD4\(^+\) T cells, triggering their activation and differentiation. This pathway is fundamental for the initiation of immune responses against extracellular pathogens and for the regulation of immune tolerance, and its dysfunction is associated with autoimmune disease, infection, and cancer. If you need structured details for a molecule rather than a pathway, specify the particular MHC class II molecule (such as "HLA-DR" or "HLA-DQ").
Inhibition of proteases (e.g., cathepsin S inhibitors prevent peptide loading onto MHC class II molecules); Broad immunosuppression (reduced antigen presentation by APCs); Blockade of co-stimulatory signals, preventing T cell activation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major histocompatibility complex class II antigen presentation pathway (MHC class II antigen presentation).